The Phase 2b trial (PMID: 23714218) failed to demonstrate significant weight loss compared to placebo over 12 weeks, despite adequate sample size and dosing
Ideal candidates include adults seeking the most comprehensive anti-aging support available, individuals wanting to address cosmetic aging, cellular health, and metabolic function simultaneously, patients committed to aggressive healthspan optimization, those interested in the most complete multi-pathway anti-aging protocol, and individuals who want maximum synergistic benefits from peptide therapy
Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, Koppula P, Wu S, Zhuang L, Fang B, Poyurovsky MV, Olszewski K, Gan B (2021) DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer
This action of Mometasone in Skinlite cream reduces the risk of developing contact dermatitis that may be caused by hydroquinone and tretinoin
Available In-Clinic & Mobile $628-$1078 Supports cellular energy, focus, and longevity by replenishing NAD levels that naturally decline with age
After 28 days, both potency and sterility become questionable